v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (18,863) $ (21,407)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 16,415 11,186
Accrued interest on marketable securities, net (75) (540)
Stock-based compensation expense 34,802 35,608
Amortization of discount and debt issuance costs 1,118 785
Loss on impairment of intangible assets 0 1,655
Deferred taxes 315 (12,006)
Changes in operating assets and liabilities:    
Accounts receivable (5,224) (7,461)
Prepaid expenses and other assets (2,098) (15,752)
Accounts payable and accrued liabilities (5,793) 4,199
Deferred costs (2,361) (2,280)
Deferred revenues (1,016) 1,506
Net cash provided by (used in) operating activities 17,220 (4,507)
Cash flows from investing activities:    
Purchase of marketable securities (23,531) (29,971)
Proceeds from sales, maturities, and redemptions of marketable securities 23,798 17,200
Purchases of property and equipment (772) (882)
Capitalized software development costs (4,065) (3,208)
Acquisition of business, net of cash acquired 0 (375,499)
Net cash used in investing activities (4,570) (392,360)
Cash flows from financing activities:    
Payments on revolving loan (15,000) (10,000)
Debt issuance costs paid 0 (1,898)
Proceeds from ESPP issuances 3,094 2,943
Proceeds from issuance of convertible senior notes 0 335,513
Proceeds from borrowing under revolving loan 0 60,000
Purchase of capped calls 0 (33,879)
Payments for taxes related to net settlement of equity awards (5,030) 0
Proceeds from stock option exercises 1,341 2,255
Repurchases of common stock (15,000) 0
Net cash (used in) provided by financing activities (30,595) 354,934
Net decrease in cash and cash equivalents (17,945) (41,933)
Cash and cash equivalents, beginning of period 63,457 94,359
Cash and cash equivalents, end of period $ 45,512 $ 52,426